Recent Research Funding

Our innovative research receives support from public and private funding sources that recognize the high-value impact of our work.

Zackary Falls, PhD

  • A translational bioinformatics approach to elucidate and mitigate polypharmacy induced adverse drug reactions. Zackary Falls (Principal Investigator). National Institute on Drug Abuse. $1,046,435. 7/1/2022-6/1/2027.
  • Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education. Zackary Falls (Co-Investigator). National Library of Medicine. $667,598. 9/1/2022-8/1/2027.
  • High-performance Computing Drug Discovery Initiative. Zackary Falls (Co-Investigator). National Institute of Standards and Technology (NIST). $1,000,000. 11/1/2022-10/1/2023.

Ram Samudrala, PhD

  • Buffalo Clinical and Translational Research Center Clinical and Translational Science Award (CTSA). Ram Samudrala (Co-Investigator). National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health. $20,178,410. 12/1/2019-12/1/2024.
  • NIH NCATS ASPIRE Design Award. Ram Samudrala (Principal Investigator). NIH. $100,000. 9/1/2019-1/1/2030.
  • NIH NCATS ASPIRE Reduction-to-Practice Award. Ram Samudrala (Co-Principal Investigator). NCATS. $1,220,000. 8/1/2021-1/1/2030.
  • Computational Analysis of Novel Drug Opportunities (CANDO). Ram Samudrala (Principal Investigator). Buffalo Innovation Accelerator Fund. $80,000. 2/1/2021-12/1/2022.
  • Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education. Ram Samudrala (Principal Investigator). NIH. $672,596. 9/1/2022-8/1/2027.
  • High performance computing drug discovery initiative. Ram Samudrala (Principal Investigator). NIST. $1,000,000. 11/1/2022-10/1/2023.
  • Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Training and Education. Ram Samudrala (Co-Investigator). NIH/NLM. $4,546,884. 7/1/2017-6/1/2027.